Neuroprotective effects and mechanisms of exercise in a chronic mouse model of Parkinson’s disease with moderate neurodegeneration
暂无分享,去创建一个
Yuen-Sum Lau | Gaurav Patki | Kaberi Das-Panja | Wei-Dong Le | S Omar Ahmad | W. Le | G. Patki | Y. Lau | S. Ahmad | K. Das-Panja | K. Das‐Panja
[1] Christopher G. Goetz,et al. Physical therapy and Parkinson's disease , 1994, Neurology.
[2] M. Mattson. Neuroprotective signaling and the aging brain: take away my food and let me run 1 1 Published on the World Wide Web on 24 August 2000. , 2000, Brain Research.
[3] M. Zigmond,et al. Neuroprotective effects of prior limb use in 6‐hydroxydopamine‐treated rats: possible role of GDNF , 2003, Journal of neurochemistry.
[4] B. Fisher,et al. Exercise‐induced behavioral recovery and neuroplasticity in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐lesioned mouse basal ganglia , 2004, Journal of neuroscience research.
[5] E. Hirsch,et al. Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death. , 2003, Human molecular genetics.
[6] A. Bauman,et al. Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. , 2007, Circulation.
[7] B. Hoffer,et al. Intranigral ventral mesencephalic grafts and nigrostriatal injections of glial cell line-derived neurotrophic factor restore dopamine release in the striatum of 6-hydroxydopamine-lesioned rats , 1998, Experimental Brain Research.
[8] G. Miller,et al. Exercise induces behavioral recovery and attenuates neurochemical deficits in rodent models of Parkinson's disease , 2003, Neuroscience.
[9] D. Garris,et al. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson’s disease , 2006, Neuroscience.
[10] M. Beal,et al. Mitochondria take center stage in aging and neurodegeneration , 2005, Annals of neurology.
[11] S. Cardoso,et al. Frontiers in Aging Neuroscience Aging Neuroscience Mitochondrial Dysfunction in the Striatum of Aged Chronic Mouse Model of Parkinson's Disease , 2022 .
[12] S. Totterdell,et al. Lysosomal malfunction accompanies alpha-synuclein aggregation in a progressive mouse model of Parkinson’s disease , 2002, Brain Research.
[13] M. Zigmond,et al. Can the brain be protected through exercise? Lessons from an animal model of parkinsonism☆ , 2003, Experimental Neurology.
[14] C. Cotman,et al. Exercise: a behavioral intervention to enhance brain health and plasticity , 2002, Trends in Neurosciences.
[15] R. Drucker-Colín,et al. A new motor test sensitive to aging and dopaminergic function , 1991, Journal of Neuroscience Methods.
[16] L. Chia,et al. Glial cell line-derived neurotrophic factor protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity in C57BL/6 mice , 1998, Neuroscience Letters.
[17] Max J Kurz,et al. Restorative effect of endurance exercise on behavioral deficits in the chronic mouse model of Parkinson's disease with severe neurodegeneration , 2009, BMC Neuroscience.
[18] Robert W. Taylor,et al. High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease , 2006, Nature Genetics.
[19] Eva Lindqvist,et al. Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons , 2007, Proceedings of the National Academy of Sciences.
[20] L. Stehno-Bittel,et al. Endurance exercise promotes cardiorespiratory rehabilitation without neurorestoration in the chronic mouse model of Parkinsonism with severe neurodegeneration , 2007, Neuroscience.
[21] K. Stecker,et al. Therapeutic value of exercise training in Parkinson's disease. , 2000, Medicine and science in sports and exercise.
[22] V. Calabrese,et al. Mitochondrial Involvement in Brain Function and Dysfunction: Relevance to Aging, Neurodegenerative Disorders and Longevity , 2001, Neurochemical Research.
[23] E. Masliah,et al. Enhanced substantia nigra mitochondrial pathology in human α-synuclein transgenic mice after treatment with MPTP 1 1 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine. , 2004, Experimental Neurology.
[24] I. Miyai,et al. Treadmill training with body weight support: its effect on Parkinson's disease. , 2000, Archives of physical medicine and rehabilitation.
[25] Jason Eibling. Physical Therapy and Parkinsonʼs Disease: A Controlled Clinical Trial , 1995 .
[26] G. Siegel,et al. Depletion of glial cell line-derived neurotrophic factor in substantia nigra neurons of Parkinson's disease brain , 2001, Journal of Chemical Neuroanatomy.
[27] V. Russell,et al. Voluntary Running Provides Neuroprotection in Rats After 6-Hydroxydopamine Injection into the Medial Forebrain Bundle , 2004, Metabolic Brain Disease.
[28] 田尻 直輝,et al. Exercise exerts neuroprotective effects on Parkinson's disease model of rats , 2010 .
[29] Joachim Klose,et al. Mitochondrial Dysfunction and Oxidative Damage in parkin-deficient Mice* , 2004, Journal of Biological Chemistry.
[30] E. Hirsch,et al. Reduced expression of brain-derived neurotrophic factor protein in Parkinson's disease substantia nigra. , 1999, Neuroreport.
[31] M. Beal. Oxidatively modified proteins in aging and disease. , 2002, Free radical biology & medicine.
[32] Fred H. Gage,et al. Exercise Enhances Learning and Hippocampal Neurogenesis in Aged Mice , 2005, The Journal of Neuroscience.
[33] Fred H. Gage,et al. An in vivo correlate of exercise-induced neurogenesis in the adult dentate gyrus , 2007, Proceedings of the National Academy of Sciences.
[34] Todd B. Sherer,et al. Chronic systemic pesticide exposure reproduces features of Parkinson's disease , 2000, Nature Neuroscience.
[35] J S Fowler,et al. PET studies of the effects of aerobic exercise on human striatal dopamine release. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[36] S. Dimauro,et al. A novel mitochondrial 12SrRNA point mutation in parkinsonism, deafness, and neuropathy , 2000, Annals of neurology.
[37] T. Yagi,et al. Neuroprotective effect of long-term NDI1 gene expression in a chronic mouse model of Parkinson disorder. , 2009, Rejuvenation research.
[38] G. Muir,et al. Treadmill training ameliorates dopamine loss but not behavioral deficits in hemi-Parkinsonian rats , 2005, Experimental Neurology.
[39] Bruce A. Yankner,et al. Dopamine-dependent neurotoxicity of α-synuclein: A mechanism for selective neurodegeneration in Parkinson disease , 2002, Nature Medicine.
[40] J. Crampton,et al. Effects of probenecid on striatal dopamine depletion in acute and long-term 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice. , 1990, General pharmacology.
[41] Syed O. Ahmad,et al. Stereologic analysis of cell number and size during postnatal development in the rat substantia nigra , 2007, Neuroscience Letters.
[42] A. Kelly,et al. Neurotrophins and their receptors: roles in plasticity, neurodegeneration and neuroprotection. , 2007, Biochemical Society transactions.
[43] A. Navarro,et al. Brain mitochondrial dysfunction in aging: conditions that improve survival, neurological performance and mitochondrial function. , 2007, Frontiers in bioscience : a journal and virtual library.
[44] K. Conley,et al. Mitochondrial Dysfunction: Impact on Exercise Performance and Cellular Aging , 2007, Exercise and sport sciences reviews.
[45] L. Novikova,et al. MPTP treatment in mice does not transmit and cause Parkinsonian neurotoxicity in non-treated cagemates through close contact , 2005, Neuroscience Research.
[46] T. Sherer,et al. Mechanistic Approaches to Parkinson's Disease Pathogenesis , 2002, Brain pathology.
[47] S. Totterdell,et al. Mouse model of Parkinsonism: a comparison between subacute MPTP and chronic MPTP/probenecid treatment , 2001, Neuroscience.
[48] G. Donnan,et al. Reduced BDNF mRNA Expression in the Parkinson's Disease Substantia Nigra , 2000, Experimental Neurology.
[49] T. Südhof,et al. Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[50] Effect of exercise on perceived quality of life of individuals with Parkinson's disease. , 2000, Journal of rehabilitation research and development.